@article{7ce31dd0383b4117b9d485f5c64ec803,
title = "Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study",
abstract = "BACKGROUND: Success of treatment withdrawal in patients with non-radiographic axial spondyloarthritis who are in remission remains unknown. The ABILITY-3 study explored the ability to withdraw adalimumab treatment in patients with non-radiographic axial spondyloarthritis who achieved sustained clinical remission after open-label treatment with adalimumab.",
author = "Robert Landew{\'e} and Joachim Sieper and Philip Mease and Inman, {Robert D.} and Lambert, {Robert G.} and Atul Deodhar and Helena Marzo-Ortega and Marina Magrey and Uta Kiltz and Xin Wang and Mei Li and Sheng Zhong and Mostafa, {Nael M.} and Apinya Lertratanakul and Pangan, {Aileen L.} and Anderson, {Jaclyn K.}",
year = "2018",
doi = "https://doi.org/10.1016/S0140-6736(18)31362-X",
language = "English",
volume = "392",
pages = "134--144",
journal = "Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "10142",
}